Funded Biotech startups in New York
Every company below filed a Form D with the SEC from a New York address. Amounts are as reported on the filing, not estimates.
Updated Jun 30, 2026
- Companies
- 12
- Total raised
- $501.6M
- Filings
- 14
- Median round
- $16.7M
- Cities
- 3
CompanyCityLast filingLatest round
Cambrian BioPharmaBio (Cambrian BioPharma, Inc.) is a New York-based…
New York
Jun 30, 2026
$123.8M
MyrtelleClinical-stage gene therapy company carrying the mission of…
New York
Jun 22, 2026
$16.7M
Illuminare BiotechnologiesClinical-stage biotechnology company in Brooklyn, New York…
Brooklyn
May 7, 2026
$3.6M
CresilonBrooklyn-based biotechnology company that develops…
Brooklyn
Apr 24, 2026
$29.0M
AtommapWhich rebranded as Fathom Therapeutics in April 2026, is a New…
New York
Mar 6, 2026
$31.1M
Inso BiosciencesEarly-stage Ithaca, New York biotechnology company building…
Ithaca
Mar 3, 2026
$750K
ImmunicLate-stage clinical biotechnology company focused on…
New York
Feb 17, 2026
$200.0M
MedicovestorEarly-stage biopharmaceutical company founded in 2023, focused…
New York
Nov 5, 2025
$3.2M
ValthosNew York-based biodefense company building frontier AI systems…
New York
Aug 14, 2025
$27.3M
Barnwell BioInnovative company dedicated to transforming animal health…
New York
Apr 4, 2025
$6.1M
Episteme PrognosticsPioneering precision medicine company dedicated to…
Brooklyn
Feb 21, 2025
$550K
Liberation LabsSpecializes in the commercialization of precision fermentation…
New York
Jan 28, 2025
$52.0M
All 12 companies · most recent filing first
Most recent filings
12All 12 companies · most recent filing first